Compare Novartis with SAT INVESTEC - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NOVARTIS vs SAT INVESTEC - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NOVARTIS SAT INVESTEC NOVARTIS/
SAT INVESTEC
 
P/E (TTM) x 85.8 17.7 483.9% View Chart
P/BV x 2.7 2.5 107.2% View Chart
Dividend Yield % 1.3 0.3 479.4%  

Financials

 NOVARTIS   SAT INVESTEC
EQUITY SHARE DATA
    NOVARTIS
Mar-21
SAT INVESTEC
Mar-21
NOVARTIS/
SAT INVESTEC
5-Yr Chart
Click to enlarge
High Rs77023 3,377.2%   
Low Rs50114 3,578.6%   
Sales per share (Unadj.) Rs154.518.1 853.1%  
Earnings per share (Unadj.) Rs8.50.8 1,012.8%  
Cash flow per share (Unadj.) Rs13.41.3 1,031.1%  
Dividends per share (Unadj.) Rs10.000.10 10,000.0%  
Avg Dividend yield %1.60.5 289.5%  
Book value per share (Unadj.) Rs289.214.9 1,946.8%  
Shares outstanding (eoy) m24.69113.09 21.8%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x4.11.0 404.9%   
Avg P/E ratio x75.122.0 341.0%  
P/CF ratio (eoy) x47.514.2 335.0%  
Price / Book Value ratio x2.21.2 177.4%  
Dividend payout %118.112.0 987.4%   
Avg Mkt Cap Rs m15,6912,081 754.1%   
No. of employees `000NANA-   
Total wages/salary Rs m1,085164 663.5%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m3,8142,048 186.2%  
Other income Rs m3323 9,764.7%   
Total revenues Rs m4,1462,051 202.1%   
Gross profit Rs m267263 101.3%  
Depreciation Rs m12252 232.3%   
Interest Rs m7790 85.4%   
Profit before tax Rs m400124 321.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m19130 639.1%   
Profit after tax Rs m20995 221.1%  
Gross profit margin %7.012.9 54.4%  
Effective tax rate %47.824.1 198.7%   
Net profit margin %5.54.6 118.7%  
BALANCE SHEET DATA
Current assets Rs m9,2242,161 426.7%   
Current liabilities Rs m3,573946 377.5%   
Net working cap to sales %148.259.3 249.7%  
Current ratio x2.62.3 113.0%  
Inventory Days Days17623 767.9%  
Debtors Days Days37954 3.9%  
Net fixed assets Rs m2,480880 281.9%   
Share capital Rs m123226 54.6%   
"Free" reserves Rs m7,0181,454 482.7%   
Net worth Rs m7,1411,680 425.0%   
Long term debt Rs m0365 0.0%   
Total assets Rs m11,7033,041 384.9%  
Interest coverage x6.22.4 260.6%   
Debt to equity ratio x00.2 0.0%  
Sales to assets ratio x0.30.7 48.4%   
Return on assets %2.46.1 40.3%  
Return on equity %2.95.6 52.0%  
Return on capital %6.710.5 63.7%  
Exports to sales %9.30-   
Imports to sales %00-   
Exports (fob) Rs m354NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m3540-   
Fx outflow Rs m97412 8,334.1%   
Net fx Rs m-621-12 5,309.6%   
CASH FLOW
From Operations Rs m-692191 -363.0%  
From Investments Rs m952-54 -1,758.6%  
From Financial Activity Rs m-368-110 335.6%  
Net Cashflow Rs m-10927 -403.3%  

Share Holding

Indian Promoters % 0.0 51.6 -  
Foreign collaborators % 70.7 0.0 -  
Indian inst/Mut Fund % 0.8 0.0 -  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 29.3 48.4 60.6%  
Shareholders   45,141 2,071 2,179.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NOVARTIS With:   REDINGTON  O P CHAINS  INDIA INFRASPACE  SHRENIK  PRITHVI EXCHANGE (INDIA)  



Today's Market

Bloodbath on Dalal Street: 6 Reasons Why Sensex Slumped 1,688 Points Today(Closing)

Indian share markets witnessed negative trading activity throughout the day today and ended deep in the red.

Related Views on News

NOVARTIS Announces Quarterly Results (3QFY20); Net Profit Down 39.9% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, NOVARTIS has posted a net profit of Rs 77 m (down 39.9% YoY). Sales on the other hand came in at Rs 1 bn (down 13.4% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

NOVARTIS Announces Quarterly Results (3QFY20); Net Profit Down 39.9% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, NOVARTIS has posted a net profit of Rs 77 m (down 39.9% YoY). Sales on the other hand came in at Rs 1 bn (down 13.4% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

More Views on News

Most Popular

Infosys vs TCS: Which is Better?(Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake(Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

How to Hit Rs 100 Crore Wealth in Your Lifetime(Equitymaster Wealth)

Nov 15, 2021

This is how you can achieve the ambitious goal of a net worth of Rs 100 crore.

Don't Sell these Stocks if the Market Falls(Profit Hunter)

Nov 17, 2021

These are the 3 types of stocks that you should not sell in a market crash.

MobiKwik IPO Opens for Subscription Soon. Key Things to Know Before Subscribing.(Views On News)

Nov 20, 2021

The Rs 19 bn issue is set to hit the market soon.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

NOVARTIS SHARE PRICE


Nov 26, 2021 (Close)

TRACK NOVARTIS

  • Track your investment in NOVARTIS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE NOVARTIS WITH

MARKET STATS